CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
Hematologic Oncology Update
00:00
How many eligible patients reach CAR T centers
Loretta and Jeremy discuss access gaps: under 20% of eligible Medicare patients reach treating centers.
Play episode from 04:57
Transcript
